3min chapter

Investing With IBD cover image

Ep. 195: Jim Roppel: Stock Market Lessons Of 2022

Investing With IBD

CHAPTER

Amgen Breaks Below Its Beautiful Digestive

I think Amgen needs to be watched very carefully. biotech and semis are really the only growth areas that have any power. And it's not, you know, although we're in a short and maybe intermediate term uptrend, it's lethargic. It's mucky.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode